
In a new podcast episode, Thomas Hope, MD, shares his insights on glioma imaging and the potential impact of the recently FDA-approved PET agent floretyrosine (18F-FET),
A 30-year-old female presents with papilledema. What is the imaging finding?
Case submitted by
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter
What is your diagnosis?




